Hyperuricemia

Gout Prevalence Is Increasing Among US Veterans

Publish Date September 22, 2021

Gout prevalence in Veterans Affairs medical centers increased from 4.2% in 2005 to 5.8% in 2014.

Single Urate Measurements Unreliable for Hyperuricemia Classification

Publish Date September 21, 2021

Consistent with previous studies, investigators documented variation in serum urate levels over time.

Hyperuricemia Is a Risk Factor for ESKD in Minimal Change Disease

Publish Date September 20, 2021

This study is the first to find an association between hyperuricemia and MCD progression in adults.

Urate-Lowering Therapies for Hyperuricemia in CKD Not Renoprotective

Publish Date September 16, 2021

Investigators examined the urate-lowering effects of febuxostat, allopurinol, and benzbromarone and their association with renal protection in CKD.

Evidence-Based Strategies Needed to Improve Outcomes for Patients Hospitalized With Gout – An Interview With Dr Brian LaMoreaux

Publish Date September 3, 2021

In an interview, Brian LaMoreaux, MD, MS, discusses the need for evidence-based strategies to improve outcomes for patients hospitalized with gout.

Novel Risk Stratification Tool Identifies Patients at High Risk for Inpatient Gout Flare

Publish Date August 23, 2021

Researchers developed and validated a gout flare risk stratification tool for patients with gout who were hospitalized for nongout conditions.

Diagnosis of Inflammatory Arthritis Tied to Impaired Male Fertility

Publish Date August 17, 2021

Men diagnosed at age 30 years or younger had a significantly lower mean number of children than those diagnosed at age 31 to 40, 41 years or older

DECT-Based MSU-Coded Plaques in Peripheral Arteries Similar Among Patients With and Without Gout

Publish Date August 13, 2021

Researchers characterized peripheral vascular plaques that were color-coded as monosodium urate deposition by DECT, and assessed their association with MSU crystal burden in soft tissues.

Urate-Lowering Therapy Associated With Decreased Gout Flare Risk

Publish Date August 11, 2021

Patients with asymptomatic hyperuricemia who achieved serum uric acid levels of 6.0 mg/dL or less while on urate-lowering therapy had fewer gout flare episodes, a study found.

Orlistat May Lower Uric Acid in Obese Population

Publish Date August 10, 2021

Obesity and dyslipidemia both increase the risk of hyperuricemia.